This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Hospitalier Universitaire De Nice, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Thierry Virolle: Innovator in Oncology
Introduction
Thierry Virolle is a notable inventor based in Puget Sur Argens, France. He has made significant contributions to the field of medicine, particularly in oncology. His work focuses on developing new compounds that can aid in the treatment of various cancers.
Latest Patents
Thierry Virolle holds a patent for "Neomycin based compounds, and pharmaceutical use thereof." This invention relates to the medical field, specifically targeting oncology. The patent provides new compounds that are useful in treating cancers such as glioblastoma, colorectal cancer, and breast cancer. Additionally, it includes pharmaceutical compositions that contain these innovative compounds.
Career Highlights
Throughout his career, Thierry has worked with esteemed institutions such as Université Côte d'Azur and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Thierry has collaborated with notable individuals in his field, including Maria Duca and Duc Duy Vo. These partnerships have further enriched his research and development efforts.
Conclusion
Thierry Virolle's innovative work in oncology demonstrates his commitment to improving cancer treatment through his patented compounds. His contributions to the medical field are invaluable and highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile